Skip to main content
Top
Published in: Journal of Genetic Counseling 6/2018

01-12-2018 | Original Research

Impact of Appointment Waiting Time on Attendance Rates at a Clinical Cancer Genetics Service

Authors: Tarryn Shaw, Julie Metras, Zoe Ang Li Ting, Eliza Courtney, Shao-Tzu Li, Joanne Ngeow

Published in: Journal of Genetic Counseling | Issue 6/2018

Login to get access

Abstract

The increase in demand for clinical cancer genetics services has impacted the ability to provide services timeously. Given limited resources, this often results in extended appointment waiting times. Over the last 3 years, the Cancer Genetics Service at the National Cancer Centre Singapore has continued to experience a steady increase in demand for its service. Nevertheless, significant no-show rates have been reported. This study sought to determine whether an association exists between appointment waiting times and attendance rates. Data was gathered for all participants meeting inclusion criteria. Attendance rates and appointment waiting times were calculated. The relationship between mean waiting times for those who did and did not attend their scheduled appointments was evaluated using Welch’s t test and linear regression model. The results showed a significant difference in mean appointment waiting times between patients who did and did not attend (32.66 versus 43.50 days respectively; p < 0.0001). Furthermore, patients who waited for longer than 37 days were significantly less likely to attend. No-show rates increased as the waiting time increased, at a rate of 19.60% per 20 days and 21.40% per 30 days. In conclusion, appointment waiting time is a significant predictor for patient attendance. Strategies to ensure patients receive an appointment within the necessary timeframe at the desired setting are important to ensure that individuals at increased cancer risk attend their appointments in order to manage their cancer risks effectively.
Literature
go back to reference Anderson, B., McLosky, J., Wasilevich, E., Lyon-Callo, S., Duquette, D. & Copeland, G. (2012). Barriers and facilitators for utilization of genetic counselling and risk assessment services in young female breast cancer survivors. Journal of Cancer Epidemiology, 2012, 1–11.CrossRef Anderson, B., McLosky, J., Wasilevich, E., Lyon-Callo, S., Duquette, D. & Copeland, G. (2012). Barriers and facilitators for utilization of genetic counselling and risk assessment services in young female breast cancer survivors. Journal of Cancer Epidemiology, 2012, 1–11.CrossRef
go back to reference Barrow, P., Green, K., Clancy, T., Lalloo, F., Hill, J., & Evans, D. G. (2015). Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey. Clinical Genetics, 87, 517–524.CrossRef Barrow, P., Green, K., Clancy, T., Lalloo, F., Hill, J., & Evans, D. G. (2015). Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey. Clinical Genetics, 87, 517–524.CrossRef
go back to reference Buchanan, A. H., Rahm, A. K., & Williams, J. L. (2016). Alternate service delivery models in cancer genetic counselling: a mini review. Frontiers in Oncology, 6(120), 1–6. Buchanan, A. H., Rahm, A. K., & Williams, J. L. (2016). Alternate service delivery models in cancer genetic counselling: a mini review. Frontiers in Oncology, 6(120), 1–6.
go back to reference Coakley, M., Cleary, V., Power, N., & O’Reilly, S. (2017). BRCA1/2 germline testing in non-mucinour epithelial ovarian carcinoma: changing international practice and implications for service provision. European Journal of Human Genetics, 25, 167–168.CrossRef Coakley, M., Cleary, V., Power, N., & O’Reilly, S. (2017). BRCA1/2 germline testing in non-mucinour epithelial ovarian carcinoma: changing international practice and implications for service provision. European Journal of Human Genetics, 25, 167–168.CrossRef
go back to reference Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., et al. (2015). Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncology, 1(7), 943–951.CrossRef Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., et al. (2015). Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncology, 1(7), 943–951.CrossRef
go back to reference Eccles, B. K., Copson, E., Maishman, T., Abraham, J. E., & Eccles, D. M. (2015). Understanding of BRCA VUS genetic results by breast cancer specialists. BMC Cancer, 15, 936.CrossRef Eccles, B. K., Copson, E., Maishman, T., Abraham, J. E., & Eccles, D. M. (2015). Understanding of BRCA VUS genetic results by breast cancer specialists. BMC Cancer, 15, 936.CrossRef
go back to reference Eccleston, A., Bentley, A., Dyer, M., Strydom, A., Vereecken, W., George, A., & Rahman, N. (2017). A cost-effective evaluation of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer. Value in Health, 20(4), 567–576.CrossRef Eccleston, A., Bentley, A., Dyer, M., Strydom, A., Vereecken, W., George, A., & Rahman, N. (2017). A cost-effective evaluation of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer. Value in Health, 20(4), 567–576.CrossRef
go back to reference Evers, C., Fischer, C., Dikow, N., & Schott, S. (2017). Familial breast cancer: Genetic counseling over time, including patients’ expectations and initiators considering the Angelina Jolie effect. PLoS One, 12(5), 1–16.CrossRef Evers, C., Fischer, C., Dikow, N., & Schott, S. (2017). Familial breast cancer: Genetic counseling over time, including patients’ expectations and initiators considering the Angelina Jolie effect. PLoS One, 12(5), 1–16.CrossRef
go back to reference Finch, A. P. M., Lubinski, J., Moller, P., Singer, C. F., Karlan, B., Senter, L., et al. (2014). Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 32(15), 1547–1563.CrossRef Finch, A. P. M., Lubinski, J., Moller, P., Singer, C. F., Karlan, B., Senter, L., et al. (2014). Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 32(15), 1547–1563.CrossRef
go back to reference Fraser, L., Bramald, S., Chapman, C., Chi, C., Cornelius, V., Douglas, F., et al. (2003). What motivates interest in attending a familial cancer genetics clinic? Familial Cancer, 2(3–4), 159–169. Fraser, L., Bramald, S., Chapman, C., Chi, C., Cornelius, V., Douglas, F., et al. (2003). What motivates interest in attending a familial cancer genetics clinic? Familial Cancer, 2(3–4), 159–169.
go back to reference Frey, M., & Pothuri, B. (2017). Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecologic Oncology Research and Practice, 4(4), 1–11. Frey, M., & Pothuri, B. (2017). Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecologic Oncology Research and Practice, 4(4), 1–11.
go back to reference Hasvold, P. E., & Wootton, R. (2011). Use of telephone and SMS reminders to improve attendance at hospital appointments: a systematic review. Journal of Telemedicine and Telecare, 17(7), 358–364.CrossRef Hasvold, P. E., & Wootton, R. (2011). Use of telephone and SMS reminders to improve attendance at hospital appointments: a systematic review. Journal of Telemedicine and Telecare, 17(7), 358–364.CrossRef
go back to reference Heald, B., Rybicki, L., Clements, D., Marquard, J., Mester, J., Noss, R., et al. (2016). Assessment of clinical workload for general and specialty genetic counselors at an academic medical center: a tool for evaluating genetic counseling practices. Nature Partner Journals: Genomic Medicine, 1, 16010. Heald, B., Rybicki, L., Clements, D., Marquard, J., Mester, J., Noss, R., et al. (2016). Assessment of clinical workload for general and specialty genetic counselors at an academic medical center: a tool for evaluating genetic counseling practices. Nature Partner Journals: Genomic Medicine, 1, 16010.
go back to reference Humphreys, L., Hunter, A. G. W., Zimak, A., O’Brien, A., Korneluk, Y., & Cappelli, M. (2000). Why patients do not attend for their appointments at a genetics clinic. Journal of Medical Genetics, 37(10), 810–815.CrossRef Humphreys, L., Hunter, A. G. W., Zimak, A., O’Brien, A., Korneluk, Y., & Cappelli, M. (2000). Why patients do not attend for their appointments at a genetics clinic. Journal of Medical Genetics, 37(10), 810–815.CrossRef
go back to reference Juthe, R. H., Zaharchuk, A., & Wang, C. (2015). Celebrity disclosures and information seeking: the case of Angelina Jolie. Genetics in Medicine, 17(7), 545–553.CrossRef Juthe, R. H., Zaharchuk, A., & Wang, C. (2015). Celebrity disclosures and information seeking: the case of Angelina Jolie. Genetics in Medicine, 17(7), 545–553.CrossRef
go back to reference Kalia, M. (2013). Personalized oncology: recent advances and future challenges. Metabolism, 62(1), 11–14.CrossRef Kalia, M. (2013). Personalized oncology: recent advances and future challenges. Metabolism, 62(1), 11–14.CrossRef
go back to reference Li, S.-T., Yuen, J., Zhou, K., Ishak, N. D. B., Chen, Y., Met-Domestici, M., et al. (2016). Impact of subsidies on cancer genetic testing uptake in Singapore. Journal of Medical Genetics, 0, 1–6. Li, S.-T., Yuen, J., Zhou, K., Ishak, N. D. B., Chen, Y., Met-Domestici, M., et al. (2016). Impact of subsidies on cancer genetic testing uptake in Singapore. Journal of Medical Genetics, 0, 1–6.
go back to reference McPherson, E., Zaleski, C., Benishek, K., McCarthy, C. A., Giampietro, P. F., Reynolds, K., et al. (2008). Clinical genetics provider real-time workflow study. Genetics in Medicine, 10(9), 699–708.CrossRef McPherson, E., Zaleski, C., Benishek, K., McCarthy, C. A., Giampietro, P. F., Reynolds, K., et al. (2008). Clinical genetics provider real-time workflow study. Genetics in Medicine, 10(9), 699–708.CrossRef
go back to reference Mohamed, K., Mustafa, A., Tahtamouni, S., Taha, E., & Hassan, R. (2016). A quality improvement project to reduce the ‘no show’ rate in a paediatric neurology clinic. The British Medical Journal, 5(1), 1–4. Mohamed, K., Mustafa, A., Tahtamouni, S., Taha, E., & Hassan, R. (2016). A quality improvement project to reduce the ‘no show’ rate in a paediatric neurology clinic. The British Medical Journal, 5(1), 1–4.
go back to reference Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.CrossRef Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.CrossRef
go back to reference Ryu, J., & Lee, T. H. (2017). The waiting game—why providers may fail to reduce wait times. The New England Journal of Medicine, 376(24), 2309–2311.CrossRef Ryu, J., & Lee, T. H. (2017). The waiting game—why providers may fail to reduce wait times. The New England Journal of Medicine, 376(24), 2309–2311.CrossRef
go back to reference Shih, Y. C., Ganz, P. A., Aberle, D., Abernethy, A., Bekelman, J., Brawley, O., et al. (2013). Delivering high-quality and affordable care throughout the cancer care continuum. Journal of Clinical Oncology, 31(32), 4151–4157.CrossRef Shih, Y. C., Ganz, P. A., Aberle, D., Abernethy, A., Bekelman, J., Brawley, O., et al. (2013). Delivering high-quality and affordable care throughout the cancer care continuum. Journal of Clinical Oncology, 31(32), 4151–4157.CrossRef
go back to reference Tan, R. Y. C., Met-Domestici, M., Zhou, K., Guzman, A. B., Lim, S. T., Soo, K. C., et al. (2016). Using quality improvement methods and time-driven activity-based costing to improve value-based cancer care delivery at a cancer genetics clinic. Journal of Oncology Practice, 12(3), 320–331.CrossRef Tan, R. Y. C., Met-Domestici, M., Zhou, K., Guzman, A. B., Lim, S. T., Soo, K. C., et al. (2016). Using quality improvement methods and time-driven activity-based costing to improve value-based cancer care delivery at a cancer genetics clinic. Journal of Oncology Practice, 12(3), 320–331.CrossRef
go back to reference Wang, V. W., Koh, P. K., Chow, W. L., & Lim, J. F. Y. (2012). Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary nonpolyposis colorectal cancer in Singapore. Familial Cancer, 11, 279–289.CrossRef Wang, V. W., Koh, P. K., Chow, W. L., & Lim, J. F. Y. (2012). Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary nonpolyposis colorectal cancer in Singapore. Familial Cancer, 11, 279–289.CrossRef
Metadata
Title
Impact of Appointment Waiting Time on Attendance Rates at a Clinical Cancer Genetics Service
Authors
Tarryn Shaw
Julie Metras
Zoe Ang Li Ting
Eliza Courtney
Shao-Tzu Li
Joanne Ngeow
Publication date
01-12-2018
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 6/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0259-z

Other articles of this Issue 6/2018

Journal of Genetic Counseling 6/2018 Go to the issue